Small for Gestational Age Infant Clinical Trial
The study was evaluated as the optimal dose for the treatment of SGA short stature children by Pegylated Somatropin, initially evaluated its efficiency and safety for the treatment of SGA short stature children and provided scientific, reliable basis for phase III clinical trials for dose selection.
This was a multicenter, randomized phase II study, half of participants will receive the high dose, while the other half will receive the low dose. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05059093 -
Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.
|
||
| Not yet recruiting |
NCT05043753 -
"Fetal gRowth AbnorMality dEtection Trial"
|
N/A | |
| Not yet recruiting |
NCT05070234 -
Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature
|
||
| Active, not recruiting |
NCT05343403 -
Parental Participation on the Neonatal Ward - the neoPARTNER Study
|
||
| Not yet recruiting |
NCT05436119 -
Select Nutrient and Gene Variant Analysis in a Targeted Diet and Lifestyle Intervention Reduces Preterm Birth
|
||
| Recruiting |
NCT04315545 -
Pregnancy Outcomes and Maternal Insulin Sensitivity
|
||
| Recruiting |
NCT03245333 -
A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)
|
Phase 3 | |
| Completed |
NCT03221933 -
A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA
|
Phase 2 | |
| Not yet recruiting |
NCT04050488 -
Zinc Supplementation on Very Low Birth Weight Infant
|
Phase 4 | |
| Recruiting |
NCT05144035 -
A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants
|
Phase 4 |